Skip to main content
. Author manuscript; available in PMC: 2019 Sep 27.
Published in final edited form as: Biotech Histochem. 2018 Sep 27;93(8):608–614. doi: 10.1080/10520295.2018.1514466

Figure 1.

Figure 1.

Flow cytometry. MDA-MB-468 and MDA-MB-231 breast cancer cells and CaOV3 negative control cells stained with osteopontin-conjugated CF594 succinimidyl ester dye. Osteopontin expression in MDA-MB-231 (27.6 ± 5.4, p = 0.0337), MDA-MB-468 (25.7 ± 2.5, p = 0.0161) breast cancer cells were compared to the least expressing osteopontin CaOV3 cells.